Bimergen Energy Corp: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Aug 14, 2019 and accepted by EDGAR at Aug 14, 2019, 20:06 ET.
Management's discussion and analysis
As filed, 9,250 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes to the financial statements included in this Form 10-Q.
Critical Accounting Policies
See Note 3 of the accompanying notes to unaudited condensed consolidated financial statements, which note is incorporated herein by reference.
Management Overview
During the fourth quarter of 2018, the decision was made to discontinue funding future medical procedures due to our cash position, which also hampers our ability to pay back existing debt to Wells Fargo and a current director and shareholder. We did not fund any procedures in 2019 and will not do so unless we can access additional capital. The service revenue we have funded has resulted in longer settlement times, which has created a slowdown in cash collections. Additionally, our efforts to establish a market for the Quad Video Halo has not met our expectations and we have cut back its development and operations; however, in late 2018 we were able to sell certain contracts to customers for the rental of our QVH units, along with image processing services.
Moving forward, our main focus will be exploring options on how to raise additional capital and expansion of our QVH services through new affiliations with spine surgeons, orthopedic surgeons and other healthcare providers across the nation.
There can be no guarantee of us continuing as a going concern if we cannot obtain additional funds. We continue to explore opportunities to raise additional capital to fund the Company’s operations.
Results of Operations
The unaudited financial statements for the six months ended June 30, 2019 and 2018 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions to Form 10-Q. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of June 30, 2019 and the results of operations and cash flows for the six months ended June 30, 2019 and 2018. The results for the six months ended June 30, 2019 are not necessarily indicative of the results to be expected for any subsequent quarter or of the entire year ending December 31, 2019.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2018 as included in our previously filed report on Form 10-K.
Comparison of the three-month period ended June 30, 2019 with the three month-period ended June 30, 2018.
The revenue for the three months ended June 30, 2019 of $11,000 consisted of $6,477 of QVH leasing revenue, and $4,523 related to excess collections for previously funded procedures. We recorded $1,054,065 in gross revenue for the three months ended June 30, 2018, offset by $449,356 of the expected variable consideration discount resulting in net revenue of $604,709. For the three months ended June 30, 2019, we funded no new procedures with spine injury diagnostic centers. For the three months ended June 30, 2018 we worked with four spine injury diagnostic centers: Houston, Texas; Tyler, Texas; Odessa, Texas and Las Cruces New Mexico, and service cost was $207,608.
During the three months ended June 30, 2019, we incurred $197,378 of operating, general and administrative expenses compared to $358,619 for the same period in 2018. Operating, general and administrative expenses were lower for the 2019 quarter compared to 2018 primarily because of decreases of $47,577 in consulting fees, $36,407 in payroll, $36,948 in bad debt expense net of recoveries, $24,028 in travel expenses, $9,658 in rent, and $6,623 in marketing expense.
As a result of the foregoing, we had net loss of $204,320 for the three months ended June 30, 2019, compared to a net profit of $22,619 for the three months ended June 30, 2018.
Comparison of the six-month period ended June 30, 2019 with the six month period ended June 30, 2018.
The revenue for the six months ended June 30, 2019 of $67,700 consisted of $24,059 of QVH leasing revenue, and $43,641 related to excess collections for previously funded procedures. For the same period in 2018, gross revenue was $2,112,188, offset by $873,053 of the settlement discount, resulting in net revenue of $1,239,135.
Service cost for the six months ended June 30, 2019 was $25,748, which consisted of inventory obsolescence write downs for the period, compared to service cost of $401,253 for the six months ended June 30, 2018, which consisted of costs associated with funding procedures for the period. No funding of procedures occurred in 2019.
During the six months ended June 30, 2019, we incurred $597,201 of operating, general and administrative expenses compared with the $695,818 for the same period in 2018. The decrease is attributable to decreases in payroll expenses of approximately $45,000, travel expense of $43,000, marketing expense of $17,000, coupled with the increase of bad debt expense net of recoveries of $5,400.
As a result of the foregoing, we had net loss of $591,820 for the six months ended June 30, 2019, compared to a net income of $112,924 for the six months ended June 30, 2018.
Liquidity and Capital Resources
For the six months ended June 30, 2019, cash provided in operations was $17,257 which primarily included decreases in accounts receivable of $513,734, decrease of related party payables of $4,967, increases in prepaid expenses of $7,350, and decreases in accounts payable and accrued liabilities of $35,599, along with non-cash operating expenses totaling $143,259. For the same period in 2018 cash used in operations was $28,187 which primarily included increases in accounts receivable of $224,265 and increases in prepaid expenses of $21,300, inventory of $15,782, accounts payable of $31,109 and a decrease in related party payables of $760. We used no cash in investing activities for the six months ended June 30, 2019 and 2018.
Cash used in financing activities for the six months ended June 30, 2019 and 2018 consisted of repayments and borrowing on our notes payable in the amount of $30,000 and $15,000, respectively.
Going Concern Considerations
Since our inception in 1998, until commencement of our spine injury diagnostic operations in August 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009. Since that time, our accumulated deficit has increased $3,815,341 to $18,820,039 as of June 30, 2019. During the six months ended June 30, 2019, we realized net losses of $591,820. Successful business operations and our transition to positive cash flows from operations are dependent upon obtaining additional financing and achieving a level of collections adequate to support our cost structure. Considering the nature of our business, we are not generating immediate liquidity and sufficient working capital within a reasonable period of time to fund our planned operations and strategic business plan through June 30, 2020. There can be no assurances that there will be adequate financing available to us.
Additionally, during the fourth quarter of 2018, the decision was made to discontinue funding future medical procedures due to our cash position, which also hampers our ability to pay back existing debt to Wells Fargo and a current director and shareholder (see Note 7—Notes Payable). We did not fund any procedures in 2019 and will not do so unless we can access additional capital. The service revenue we have funded has resulted in longer settlement times, which has created a slowdown in cash collections. Additionally, our efforts to establish a market for the Quad Video Halo has not met our expectations and we have cut back its development and operations. If we are unable to access additional capital in the near future or enter into a strategic alternative transaction, these recent developments could have a material negative impact on our financial performance and could have a material adverse effect on our results of operations and financial condition. The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.
Controls and procedures
As filed, 2,441 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our principal executive officer and principal financial officer are responsible for establishing and maintaining our disclosure controls and procedures. Such officers have concluded (based upon their evaluation of these controls and procedures as of the end of the period covered by this report) that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in this report is accumulated and communicated to management, including our principal executive and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.
Our principal executive officer and principal financial officer have also indicated that, upon evaluation, there were no changes in our internal control over financial reporting or other factors during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Risk factors
As filed, 457 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information set forth in this report, one should carefully consider the discussion of various risks and uncertainties contained in Part I, Item 1A, “Risk Factors” in our 2018 Annual Report on Form 10-K. We believe the risk factors presented in this filing and those presented on our 2018 Form 10-K are the most relevant to our business and could cause our results to differ materially from any forward-looking statements made by us.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-04-01 to 2019-06-30 | $11.0k | us-gaap:Revenues |
| Revenue | 6 months2019-01-01 to 2019-06-30 | $67.7k | us-gaap:Revenues |
| Cost of revenue | 3 months2019-04-01 to 2019-06-30 | $0 | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2019-01-01 to 2019-06-30 | $25.7k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2019-04-01 to 2019-06-30 | $11.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2019-01-01 to 2019-06-30 | $42.0k | us-gaap:GrossProfit |
| Operating income | 3 months2019-04-01 to 2019-06-30 | −$186.4k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-01-01 to 2019-06-30 | −$555.2k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-04-01 to 2019-06-30 | $18.5k | us-gaap:InterestExpense |
| Interest expense | 6 months2019-01-01 to 2019-06-30 | $37.7k | us-gaap:InterestExpense |
| Net income | 3 months2019-04-01 to 2019-06-30 | −$204.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | −$591.8k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | $17.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2019-06-30 | $46.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-06-30 | $933.0k | us-gaap:AssetsCurrent |
| Total assets | At period end2019-06-30 | $2.7m | us-gaap:Assets |
| Current liabilities | At period end2019-06-30 | $1.7m | us-gaap:LiabilitiesCurrent |
| Current portion of debt | At period end2019-06-30 | $60.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2019-06-30 | $1.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001185185-19-001148. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.